With strong commitment, Venus has metamorphosed to feature among the leaders providing innovative solutions to unmet medical needs in the field of Antimicrobial Resistance (AMR), Oncology, Skin & Wound care, Pain management. The Company has the right blend of spectrum, vision,talent and capabilities that we believe will enable us to actualize our goal.
Our GLP accredited Venus Medicine Research Centre (VMRC) is committed to bring to the world novel breakthroughs that cater to critical care and super speciality segments.
TROIS is a powerful nanotech emulsion with unique blend of essential oils of natural origin for multi-action topical application, which has potent analgesic & anti- inflammatory effects. Being a nanotech emulsion TROIS is absorbed quickly into the skin to give better, quicker & long lasting relief from pain. TROIS emulsion is non-greasy, non-Irritant, well tolerated and absorbed within seconds. TROIS is available as 50ml in specially designed, easy to handle glass bottle with Soft Roll-On. "Soft Roll-On" over glass bottle of TROIS permits emulsion to spread easily and quickly on the applied area by keeping hands neat and clean. Recently, the company
had launched new SKU of Trois in Nanogel Form for targetting more localized pain conditions.
Ampcuare / Septiloc is a Novel Topical Herbal Wound Healing Product for Chronic Non Healing Wounds. Winner of Best innovation award – 2010 under India Innovation Growth Program organized by Department of Science & Technology (DST), India, Lockheed Martin, USA, FICCI, India. Recently, we have launched new SKU of Septiloc in ointment form for targetting minor cuts and infections.
Elores is a novel patented Antibiotic Adjuvant Entity containing a beta-lactam antibiotic, a beta-lactamase inhibitor and an Antibiotic Resistance Breaker (ARB).
It is a novel combination of Ceftriaxone (third generation beta-lactam Cephalosporin), Sulbactam (beta-lactamase inhibitor) and Disodium EDTA (Class 1 Antibiotic Resistance Breaker), and it restores the in vitro activity of Ceftriaxone against ESBL/MBL producing gram-negative bacteria, including enzyme families that belong to Ambler class A (TEM,
SHV,CTX-M), class B (NDM, VIM, IMP), class C (some variants of AmpC), and class D (OXA ESBLs).